Apg Asset Management N.V. Exelixis, Inc. Transaction History

Apg Asset Management N.V.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$18.17 - $20.48 $2.35 Million - $2.65 Million	129,200 New	129,200 $2.47 Million
Q2 2021 Aug 13, 2021	SELL	$17.95 - $25.56 $3.14 Million - $4.47 Million	-174,700 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$18.39 - $24.8 $588,480 - $793,600	32,000 Added 22.42%	174,700 $2.87 Million
Q3 2020 Nov 12, 2020	BUY	$20.67 - $26.94 $2.33 Million - $3.03 Million	112,600 Added 374.09%	142,700 $2.98 Million
Q2 2020 Aug 14, 2020	BUY	$16.46 - $27.42 $495,446 - $825,342	30,100 New	30,100 $636,000
Q1 2020 May 14, 2020	SELL	$14.46 - $21.8 $1.29 Million - $1.94 Million	-89,100 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$15.15 - $18.89 $223,447 - $278,608	14,749 Added 19.84%	89,100 $1.4 Million
Q3 2019 Nov 08, 2019	BUY	$17.68 - $22.65 $1.31 Million - $1.68 Million	74,351 New	74,351 $1.21 Million

541

245M

2.84M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.8B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

Stay updated on Apg Asset Management N.V. with notifications on news.